His main research concerns Immunology, Rheumatoid arthritis, Arthritis, Internal medicine and Synovial membrane. Borrowing concepts from Synovial fluid, Gabriel S. Panayi weaves in ideas under Immunology. His Rheumatoid arthritis research incorporates elements of Erythrocyte sedimentation rate, Autoimmune disease and Penicillamine.
His work on Type II collagen as part of general Arthritis research is frequently linked to Arthropathy, thereby connecting diverse disciplines of science. His Internal medicine research includes elements of Gastroenterology, Endocrinology and Surgery. His Synovial membrane study deals with Pathology intersecting with Interdigitating Cells, Granulocyte macrophage colony-stimulating factor, Macrophage, HLA-DR and Cell type.
Immunology, Rheumatoid arthritis, Internal medicine, Arthritis and Antibody are his primary areas of study. In his works, Gabriel S. Panayi performs multidisciplinary study on Immunology and Synovial fluid. Within one scientific family, he focuses on topics pertaining to Cytokine under Rheumatoid arthritis, and may sometimes address concerns connected to Tumor necrosis factor alpha and Peripheral blood mononuclear cell.
His study in the field of Rheumatology is also linked to topics like Placebo. He works in the field of Arthritis, namely Synovial membrane. Gabriel S. Panayi has included themes like Immune system and Pathology in his Antigen study.
Gabriel S. Panayi spends much of his time researching Immunology, Rheumatoid arthritis, Internal medicine, Arthritis and Rheumatology. His Immunology study combines topics from a wide range of disciplines, such as Peripheral blood mononuclear cell and Binding immunoglobulin protein. The various areas that Gabriel S. Panayi examines in his Rheumatoid arthritis study include Autoimmune disease, Disease, Shared epitope and Adverse effect.
His Internal medicine study integrates concerns from other disciplines, such as Physical therapy and Surgery. Gabriel S. Panayi combines subjects such as Transgene, Bone remodeling and Interleukin 4 with his study of Arthritis. His work carried out in the field of Rheumatology brings together such families of science as Dermatology, Juvenile, Antibody level, Cytokine secretion and Occupational therapy.
Immunology, Rheumatoid arthritis, Tumor necrosis factor alpha, Arthritis and Internal medicine are his primary areas of study. His Immunology study combines topics in areas such as Extracellular and Cytotoxic T cell. His work in Tumor necrosis factor alpha covers topics such as Cytokine which are related to areas like Natural killer cell.
Gabriel S. Panayi does research in Arthritis, focusing on Type II collagen specifically. His study looks at the intersection of Internal medicine and topics like Surgery with Cardiology. His study focuses on the intersection of Autoimmune disease and fields such as Immunopathology with connections in the field of Antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Ernest H.S. Choy;Gabriel S. Panayi.
The New England Journal of Medicine (2001)
RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION
G. Janossy;G. Janossy;O. Duke;O. Duke;L.W. Poulter;L.W. Poulter;G. Panayi;G. Panayi.
The Lancet (1981)
Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled, dose‐escalation trial
Ernest Choy;D A Isenberg;Toby Garrood;S Farrow.
Arthritis & Rheumatism (2002)
The importance of the t cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis
G. S. Panayi;J. S. Lanchbury;G. H. Kingsley.
Arthritis & Rheumatism (1992)
Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis
Ian C. Chikanza;Petros Petrou;Gabrielle Kingsley;George Chrousos.
Arthritis & Rheumatism (1992)
HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region.
B. P. Wordsworth;J. S. S. Lanchbury;L. I. Sakkas;K. I. Welsh.
Proceedings of the National Academy of Sciences of the United States of America (1989)
Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis.
M N Farahat;G Yanni;R Poston;G S Panayi.
Annals of the Rheumatic Diseases (1993)
THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITIS
E. C. C. Rankin;E. H. S. Choy;D. Kassimos;G. H. Kingsley.
A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide.
S M Wellicome;M H Thornhill;C Pitzalis;D S Thomas.
Journal of Immunology (1990)
An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies.
O Duke;G S Panayi;G Janossy;L W Poulter.
Clinical and Experimental Immunology (1982)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: